Page 4 - Sarah Shew News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sarah shew. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sarah Shew Today - Breaking & Trending Today

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2021

/PRNewswire/ Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2021, which include the consolidated. ....

United States , North Carolina , Menlo Park , United Kingdom , San Diego , Sarah Shew , Pacific Biosciences , National Cancer Center Japan , Boehringer Ingelheim , Jean Perrin Center , Prnewswire Illumina Inc , Alignment Health Plan , European Commission , News Center , Exchange Commission , Illumina Genomics Forum , Participation In Our Future Health , Illumina Inc , Clermont Ferrand University Hospital , Reconciliation Between , Chief Executive , Core Illumina , Illumina Itemized Reconciliation Between , Trusight Oncology , Future Health , Nashville Biosciences ,

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2021

/PRNewswire/ Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2021, which include the consolidated. ....

United States , North Carolina , Menlo Park , United Kingdom , San Diego , Sarah Shew , Pacific Biosciences , National Cancer Center Japan , Boehringer Ingelheim , Jean Perrin Center , Prnewswire Illumina Inc , Alignment Health Plan , European Commission , News Center , Exchange Commission , Illumina Genomics Forum , Participation In Our Future Health , Illumina Inc , Clermont Ferrand University Hospital , Reconciliation Between , Chief Executive , Core Illumina , Illumina Itemized Reconciliation Between , Trusight Oncology , Future Health , Nashville Biosciences ,

Cardinal Health reports third-quarter results for fiscal year 2021

Share this article
Share this article
DUBLIN, Ohio, May 6, 2021 /PRNewswire/ Cardinal Health (NYSE: CAH) today reported third-quarter fiscal year 2021 revenue of $39.3 billion, in-line with the third quarter of last year. Third-quarter GAAP operating earnings decreased 16% to $473 million, primarily due to the write-down of the net assets held for sale from the planned divestiture of the Cordis business. Third-quarter GAAP diluted earnings per share (EPS) decreased to $0.40, due to the previously-disclosed tax effect of the litigation charge in the first quarter.
Non-GAAP operating earnings decreased 4% to $689 million in the quarter due to the negative impact from COVID-19, primarily concentrated in the Pharmaceutical segment. Non-GAAP diluted EPS decreased 6% to $1.53 in the quarter, reflecting a higher non-GAAP effective tax rate, partially offset by lower interest expense. ....

United States , Sarah Shew , Hellman Friedman , Mike Kaufmann , Kevin Moran , Specialty Solutions , Us Department Of Health , Human Services , Cardinal Health Form , Cardinal Health Board Of Directors , Tech Solutions , Cardinal Health , Cardinal Health Specialty Solutions , Strategic National Stockpile , Cardinal Health Inc , Pharmaceutical Distribution , Health Board , Health Specialty Solutions , America Healthcare Conference , Investor Relations , Consolidated Statements , Coronavirus Aid , Economic Security , Cash Flows , ஒன்றுபட்டது மாநிலங்களில் , சாரா காட்டு ,

Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman

Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman
USA - English
Share this article
Share this article
DUBLIN, Ohio, March 12, 2021 /PRNewswire/ Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion, which includes buyer s assumption of certain liabilities and seller s retention of certain working capital accounts. The transaction is expected to close in the first half of Cardinal Health s fiscal year 2022, subject to customary closing conditions and regulatory clearances.
Cordis has a long history of innovation in minimally-invasive cardiovascular technology, and we are confident that with H&F as its owner, Cordis will be well-positioned for growth, innovation and success, said Mike Kaufmann, CEO of Cardinal Health. Cardinal Health and H&F have a shared passion for delivering high-quality medical p ....

United States , Sarah Shew , Hellman Friedman , Mike Kaufmann , Duke Rohlen , Kevin Moran , Hunter Philbrick , Deutsche Bank Securities Inc , Jp Morgan Securities , Ajax Health , Meagher Flom , We At Ajax Health , Kirkland Ellis , Cardinal Health Form , Hf Cardinal Health , Investment Bank , Cardinal Health , Zeus Health , Cordis Accelerator , Executive Chairman Designate , Deutsche Bank Securities , Menlo Park , Healthquest Capital , Polaris Partners , ஒன்றுபட்டது மாநிலங்களில் , சாரா காட்டு ,

Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman

Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Sarah Shew , Hellman Friedman , Mike Kaufmann , Duke Rohlen , Kevin Moran , Hunter Philbrick , Deutsche Bank Securities Inc , Jp Morgan Securities , Ajax Health , Meagher Flom , We At Ajax Health , Kirkland Ellis , Cardinal Health Form , Hf Cardinal Health , Investment Bank , Cardinal Health , Zeus Health , Cordis Accelerator , Executive Chairman Designate , Deutsche Bank Securities , Menlo Park , Healthquest Capital , Polaris Partners , ஒன்றுபட்டது மாநிலங்களில் , சாரா காட்டு ,